Translating T Cell Responses Generated by Vaccines into Lasting Benefits for Patients

Time: 11:30 am
day: Focus Day


  • Discussing the powerful combination immunotherapies that are needed for the
    treatment of metastatic patents
  • Determining the vaccination platform, the magnitude and quality of neoantigen
    induced T cells
  • Interrogating T cells infiltrating the tumour to dissect the relative contribution of
    vaccine induced T cells